17-43070958-C-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 4P and 20B. PM1PM5BP4_StrongBP6_Very_StrongBS1BS2

The NM_007294.4(BRCA1):​c.4956G>A​(p.Met1652Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0146 in 1,614,160 control chromosomes in the GnomAD database, including 338 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M1652R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.014 ( 26 hom., cov: 32)
Exomes 𝑓: 0.015 ( 312 hom. )

Consequence

BRCA1
NM_007294.4 missense

Scores

5
12

Clinical Significance

Benign reviewed by expert panel U:3B:41O:1

Conservation

PhyloP100: 1.31

Publications

126 publications found
Variant links:
Genes affected
BRCA1 (HGNC:1100): (BRCA1 DNA repair associated) This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]
BRCA1 Gene-Disease associations (from GenCC):
  • BRCA1-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Fanconi anemia, complementation group S
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • pancreatic cancer, susceptibility to, 4
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

PM1
In a hotspot region, there are 8 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 18 benign, 78 uncertain in NM_007294.4
PM5
Other missense variant is known to change same aminoacid residue: Variant chr17-43070958-CA-TT is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 665843.
BP4
Computational evidence support a benign effect (MetaRNN=0.0070306957).
BP6
Variant 17-43070958-C-T is Benign according to our data. Variant chr17-43070958-C-T is described in ClinVar as Benign. ClinVar VariationId is 41830.Status of the report is reviewed_by_expert_panel, 3 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0138 (2106/152288) while in subpopulation SAS AF = 0.0323 (156/4830). AF 95% confidence interval is 0.0282. There are 26 homozygotes in GnomAd4. There are 1188 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 26 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_007294.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA1
NM_007294.4
MANE Select
c.4956G>Ap.Met1652Ile
missense
Exon 15 of 23NP_009225.1P38398-1
BRCA1
NM_001407581.1
c.5022G>Ap.Met1674Ile
missense
Exon 16 of 24NP_001394510.1A0A2R8Y7V5
BRCA1
NM_001407582.1
c.5022G>Ap.Met1674Ile
missense
Exon 16 of 24NP_001394511.1A0A2R8Y7V5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA1
ENST00000357654.9
TSL:1 MANE Select
c.4956G>Ap.Met1652Ile
missense
Exon 15 of 23ENSP00000350283.3P38398-1
BRCA1
ENST00000471181.7
TSL:1
c.5019G>Ap.Met1673Ile
missense
Exon 16 of 24ENSP00000418960.2P38398-7
BRCA1
ENST00000470026.6
TSL:1
c.4956G>Ap.Met1652Ile
missense
Exon 15 of 23ENSP00000419274.2P38398-1

Frequencies

GnomAD3 genomes
AF:
0.0138
AC:
2104
AN:
152170
Hom.:
26
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00188
Gnomad AMI
AF:
0.00769
Gnomad AMR
AF:
0.00425
Gnomad ASJ
AF:
0.0230
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.0317
Gnomad FIN
AF:
0.0555
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0162
Gnomad OTH
AF:
0.0110
GnomAD2 exomes
AF:
0.0180
AC:
4515
AN:
250924
AF XY:
0.0202
show subpopulations
Gnomad AFR exome
AF:
0.00185
Gnomad AMR exome
AF:
0.00416
Gnomad ASJ exome
AF:
0.0232
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0515
Gnomad NFE exome
AF:
0.0152
Gnomad OTH exome
AF:
0.0179
GnomAD4 exome
AF:
0.0147
AC:
21500
AN:
1461872
Hom.:
312
Cov.:
31
AF XY:
0.0158
AC XY:
11467
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.00194
AC:
65
AN:
33480
American (AMR)
AF:
0.00461
AC:
206
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0229
AC:
599
AN:
26136
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39700
South Asian (SAS)
AF:
0.0361
AC:
3113
AN:
86258
European-Finnish (FIN)
AF:
0.0484
AC:
2587
AN:
53406
Middle Eastern (MID)
AF:
0.0241
AC:
139
AN:
5768
European-Non Finnish (NFE)
AF:
0.0125
AC:
13948
AN:
1112006
Other (OTH)
AF:
0.0139
AC:
839
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
1268
2536
3803
5071
6339
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
482
964
1446
1928
2410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0138
AC:
2106
AN:
152288
Hom.:
26
Cov.:
32
AF XY:
0.0160
AC XY:
1188
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.00188
AC:
78
AN:
41552
American (AMR)
AF:
0.00425
AC:
65
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0230
AC:
80
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5192
South Asian (SAS)
AF:
0.0323
AC:
156
AN:
4830
European-Finnish (FIN)
AF:
0.0555
AC:
588
AN:
10600
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0162
AC:
1104
AN:
68026
Other (OTH)
AF:
0.0109
AC:
23
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
108
215
323
430
538
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0145
Hom.:
73
Bravo
AF:
0.00878
TwinsUK
AF:
0.0132
AC:
49
ALSPAC
AF:
0.00960
AC:
37
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.0152
AC:
131
ExAC
AF:
0.0176
AC:
2139
Asia WGS
AF:
0.0100
AC:
36
AN:
3478
EpiCase
AF:
0.0146
EpiControl
AF:
0.0151

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
12
Breast-ovarian cancer, familial, susceptibility to, 1 (14)
-
-
11
not specified (12)
-
-
6
not provided (6)
-
-
5
Hereditary breast ovarian cancer syndrome (5)
-
1
4
Hereditary cancer-predisposing syndrome (5)
-
-
1
BRCA1-related cancer predisposition (1)
-
-
1
Familial cancer of breast (1)
-
-
1
Malignant tumor of breast (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.39
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Uncertain
-0.030
CADD
Benign
18
DANN
Benign
0.97
DEOGEN2
Benign
0.10
T
Eigen
Benign
-0.27
Eigen_PC
Benign
-0.067
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Uncertain
0.89
D
MetaRNN
Benign
0.0070
T
MetaSVM
Benign
-0.85
T
MutationAssessor
Benign
0.17
N
PhyloP100
1.3
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-1.2
N
REVEL
Uncertain
0.43
Sift
Benign
0.32
T
Sift4G
Benign
0.23
T
Polyphen
0.0
B
Vest4
0.14
MPC
0.091
ClinPred
0.0072
T
GERP RS
3.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.20
gMVP
0.30
Mutation Taster
=69/31
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1799967; hg19: chr17-41222975; COSMIC: COSV58787197; API